Institutional Ownership Dermata Therapeutics Inc Wt Ex (DRMAW)
This table provides information about the institutional ownership of Dermata Therapeutics Inc Wt Ex (DRMAW). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 205,453 shares, which have been reported (via 13F filing form) to have a value of $4,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
175,000
shares
|
$3,500
0.1% of portfolio
|
Q4 2021
New holding
|
|
|
Two Sigma Securities, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
12,857
shares
|
$257
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
12,000
shares
|
$240
0.0% of portfolio
|
Q3 2021
New holding
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
4,142
shares
|
$82
0.0% of portfolio
|
Q4 2024
Reduced 2.36%
|
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,354
shares
|
$27
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
100
shares
|
$2
0.0% of portfolio
|
Q3 2024
Reduced 50.0%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|